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Stereotactic ablative radiotherapy (SABR) for early-stage non–small-cell lung cancer achieves local control rates 
approaching 90%, however, toxicity is increased when treat-
ing central tumors.1 Risk-adapted schedules can reduce this, 
however, a case of fatal central airway necrosis occurring 11 
months after SABR was recently reported despite such an 
approach,2 suggesting the requirement for a detailed assess-
ment of all contributory factors.
A 78-year-old man presented with hemoptysis in 
January 2011. Bronchoscopy showed thickening and erythema 
at the left main bronchial bifurcation and staging fluorode-
oxyglucose (FDG)-positron emission tomography computed 
tomography (PET CT) showed increased uptake, Figure 1. 
Biopsy confirmed a 42-mm cT2aN0M0 squamous cell car-
cinoma. Medical history included type II diabetes mellitus, 
myocardial infarction, cerebrovascular accident, and chronic 
obstructive pulmonary disease (forced expiratory volume in 
1 second 1.64, 64% of predicted value). A multidisciplinary 
tumor board concluded a pneumonectomy would be required 
and, given the operative risks, recommended radiotherapy. 
The patient elected for SABR and was referred to our hospital.
A schedule of 60 Gy in eight 7.5 Gy fractions was pre-
scribed to the 80% isodose, and treatment planned ensuring 
this encompassed 95% of the planning target volume (PTV). 
This guideline-recommended prescribing pattern increases 
doses within the PTV, with the major bronchi receiving a 
maximum planned dose of 75 Gy, whereas the remaining PTV 
received 84 Gy, Figure 2. Immediately before treatment each 
day, a cone-beam CT was acquired to ensure setup accuracy. 
In this case, inaccurate setup did not increase delivered doses 
from that which was planned.
The patient developed cough and shortness of breath 12 
months posttreatment. A CT revealed left lung atelectasis and 
bronchoscopy confirmed total occlusion of the left main bron-
chus with apparent necrotic tumor, Figure 3. Eight biopsies, 
brushings, and a restaging FDG-PET CT, however, suggested 
no evidence of recurrence. A further FDG-PET CT 26 months 
posttreatment, again confirmed no increased uptake. Since the 
initial collapse of his left lung, the patient’s shortness of breath 
has remained stable. He currently requires home help for 
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FIGURE 1.  Bronchoscopic and representative axial and 
coronal FDG-positron emission tomography images showing 
a T2aN0M0 squamous cell carcinoma adjacent to the bifurca-
tion of the left main bronchus (white arrow).
FIGURE 2.  Axial and coronal computed tomography images 
with the planned radiotherapy dose shown from 60 to 84 
Gy (graduated color scale from blue to red) delivered to the 
planning target volume (cyan). Note the dose-gradient with 
the 75 Gy isodose (red) and higher doses adjacent to the 
major bronchi (yellow).
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showering and using a mobility scooter. Despite this, he con-
tinues to leave his home daily, visits relatives and describes 
satisfaction with his quality of life.
Although this is the first case of total lung atelectasis 
we observed after treating more than 120 tumors in proxim-
ity to the central airways with SABR, such findings may be 
significantly under appreciated. Song et al.3 found bronchial 
stenosis occurred in 89% (8 of 9) of central tumors, using a 
wide range of schedules, and that the median time to occur-
rence was 20.5 months. In addition, Miller et al.4 found a 25% 
risk of bronchial stenosis with conventional radiotherapy to 86 
Gy in 43 fractions, which is biologically less potent than most 
risk-adapted SABR schedule.
The treatment of central tumors represents a high-risk 
clinical situation with any treatment modality. Although bron-
choplastic procedures may spare selected patients pneumo-
nectomy, the 30-day mortality and complication rates are still 
4.5% and 25%, respectively.5 The risks of mortality and high-
grade toxicity with SABR for central tumors of 1% and 9% 
should therefore be considered in this context1 and with the 
consequences of untreated lung cancer.
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FIGURE 3.  Bronchoscopic, axial FDG-PET CT and coronal 
CT images showing complete obstruction of the left main 
bronchus and total left lung atelectasis. Note the absence of 
increased FDG-PET uptake confirming the absence of tumor 
recurrence. FDG-PET CT, positron emission tomography 
 computed tomography.
